Company profile: Clinical Trial Connect
1.1 - Company Overview
Company description
- Provider of a platform for disease foundations and advocacy groups to connect community members with relevant clinical trials. Citeline Connect accelerates clinical trial enrollment by connecting sponsors, recruitment partners, patients, healthcare providers, and sites through educational content, engagement strategies, and a globally compliant data analytics platform.
Products and services
- Citeline Connect: A platform engineered to accelerate clinical trial enrollment by connecting sponsors, recruitment partners, patients, healthcare providers, and sites through educational content, engagement strategies, and a globally compliant data analytics platform
- Clinical Trial Connect Platform: Used by disease foundations and advocacy groups, this platform connects community members to relevant clinical trials across patient communities
- Globally Compliant Data Analytics Platform: Supports Citeline Connect by enabling globally compliant analytics to connect sponsors, recruitment partners, patients, healthcare providers, and sites.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clinical Trial Connect
Author-it
HQ: United States
Website
- Description: Provider of enterprise software for authoring, content management, publishing, and localization, including Author-it CCMS for creating, managing, and multi-channel publishing of technical documentation and eLearning; Docuvera for structured authoring in life sciences and pharmaceutical industries; cloud-based eLearning authoring with xAPI/SCORM and LMS integration; plus support, implementation, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Author-it company profile →
Deciphex
HQ: Ireland
Website
- Description: Provider of AI-powered digital pathology solutions and services. Offers Diagnexia for remote diagnostic consultations and backlog reduction via a network of subspecialty pathologists, and Patholytix for accelerating drug development, including web-based workflow tools, Foresight decision support for toxicologic pathology, and AI analytics on whole slide images.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deciphex company profile →
SmartLabs
HQ: United States
Website
- Description: Provider of labs and lab operations, building and operating multi-use R&D labs, vivariums, process development, and manufacturing suites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SmartLabs company profile →
Accutar Bio
HQ: China
Website
- Description: Provider of AI-driven drug discovery solutions, including ChemiRise for end-to-end retrosynthesis via a graph convolutional one-step reaction proposer; Chemi-Net for ADME prediction; targeted protein degradation (ER degraders for breast cancer, AR degraders for prostate cancer); an orbital docking platform from SMILES with conformational error detection; virtual screening validated by crystallization; and an AI platform for novel small molecule discovery for chronic inflammatory diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accutar Bio company profile →
Synthesis Med Chem
HQ: United States
Website
- Description: Provider of small molecule drug discovery services, offering integrated drug discovery from hit identification to preclinical candidate nomination; medicinal and synthetic chemistry; custom synthesis; targeted protein degradation (PROTACs & molecular glues); antibody-drug conjugate development; and hit discovery supported by protein production and structural biology services from Viva Biotech.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synthesis Med Chem company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clinical Trial Connect
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clinical Trial Connect
2.2 - Growth funds investing in similar companies to Clinical Trial Connect
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clinical Trial Connect
4.2 - Public trading comparable groups for Clinical Trial Connect
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →